Payden & Rygel
- SEC CIK
- 0000919219
- Latest filing
- Jul 31, 2026
DGX holding history
Quest Diagnostics Inc in every 13F filed by Payden & Rygel, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DGX overviewAll 13F holders of DGXFull Q2 2026 holdings
- Shares (Q2 2026)
- 92,740
- Value
- $19.7M
- % of portfolio
- 1.5%
- Quarters held
- 5
- Since Q2 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 92,740 | $19.7M | 1.5% | +16,140+21.1% | Added | Holders |
| Q1 2026 | 76,600 | $15.0M | 1.2% | −16,800−18.0% | Reduced | Holders |
| Q4 2025 | 93,400 | $16.2M | 1.1% | −800−0.8% | Reduced | Holders |
| Q3 2025 | 94,200 | $18.0M | 1.5% | +600+0.6% | Added | Holders |
| Q2 2025 | 93,600 | $16.8M | 1.4% | +93,600 | New | Holders |